Ketamine augmentation for major depressive disorder and suicidal ideation: Preliminary experience in an inpatient psychiatry setting
Mark Sinyor(Sunnybrook Health Science Centre), Ayal Schaffer(University of Toronto), Marissa Williams, Saulo Castel(Sunnybrook Health Science Centre), Beverley A. Orser(Sunnybrook Health Science Centre), Anthony Levitt(University of Toronto), Margaret Vincent(University of Limerick), Linda Mah(University of Toronto), Carlos A. Zarate(National Institute of Mental Health), S. Belo(Sunnybrook Health Science Centre)
Cited by 36
Related Papers
Canadian Network for Mood and Anxiety Treatments (<scp>CANMAT</scp>) and International Society for Bipolar Disorders (<scp>ISBD</scp>) 2018 guidelines for the management of patients with bipolar disorder
|Bipolar Disorders|2018|1.8k
Suicide risk and prevention during the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.6k
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013
|Bipolar Disorders|2012|1.2k
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder
|The Canadian Journal of Psychiatry|2016|1.1k
The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders
|American Journal of Psychiatry|2013|754